| 1 |
35176901 | Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. | 2022 Jan-Dec |
3 |
| 2 |
32994805 | Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity. | 2020 |
2 |
| 3 |
29031211 | Cyanidin-3-O-glucoside inhibits the UVB-induced ROS/COX-2 pathway in HaCaT cells. | 2017 Dec |
1 |
| 4 |
25851346 | Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. | 2015 Aug |
3 |
| 5 |
23172668 | Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling. | 2013 Mar |
2 |
| 6 |
22200683 | Celecoxib suppresses fibroblast proliferation and collagen expression by inhibiting ERK1/2 and SMAD2/3 phosphorylation. | 2012 Mar |
1 |
| 7 |
22415852 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. | 2012 Jul |
2 |
| 8 |
21807123 | The acid sphingomyelinase inhibitors block interferon-α-induced serotonin uptake via a COX-2/Akt/ERK/STAT-dependent pathway in T cells. | 2011 Nov |
1 |
| 9 |
20682995 | Antiproliferative effect of a novel nitro-oxy derivative of celecoxib in human colon cancer cells: role of COX-2 and nitric oxide. | 2010 Jul |
1 |
| 10 |
20717005 | Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines. | 2010 Oct |
9 |
| 11 |
20848776 | [Effects of EGFR inhibitor AG1478 in combination with celecoxib on the growth of gastric cancer cells]. | 2010 Jul |
1 |
| 12 |
21044953 | ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1. | 2010 Dec 31 |
3 |
| 13 |
19558494 | Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways. | 2009 Nov |
1 |
| 14 |
19682443 | Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth. | 2009 Dec 10 |
1 |
| 15 |
18080123 | Celecoxib inhibits production of MMP and NO via down-regulation of NF-kappaB and JNK in a PGE2 independent manner in human articular chondrocytes. | 2008 Jun |
2 |
| 16 |
18172786 | Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. | 2008 |
1 |
| 17 |
18296338 | The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets. | 2008 |
1 |
| 18 |
16169610 | Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways. | 2006 Mar 15 |
1 |
| 19 |
16949034 | Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. | 2006 Oct 20 |
1 |
| 20 |
15265936 | Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. | 2004 Aug 1 |
1 |
| 21 |
12464646 | Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. | 2002 Dec 4 |
2 |